CLINICAL TRIAL
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
An abstract is available from the original source but is not redistributed by this tracker. Read the source record.